Outlook Therapeutics, Inc.
OTLK • NASDAQ • Stock Fundamentals
Outlook Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Charles Jahr, with a market cap of $37.5M.
Market Cap$37.5M
Employees24.0
CEORobert Charles Jahr
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 12 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Outlook Therapeutics, Inc. FAQ
Common questions about Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. (OTLK) has a market capitalization of $37.5M and trades on NASDAQ.
Outlook Therapeutics, Inc. has approximately 24 employees.